Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX)

Jane Street Group LLC bought a new stake in Co-Diagnostics, Inc. (NASDAQ:CODX) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 44,124 shares of the company’s stock, valued at approximately $55,000. Jane Street Group LLC owned 0.14% of Co-Diagnostics at the end of the most recent reporting period.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “neutral” rating and set a $1.50 price target on shares of Co-Diagnostics in a research note on Monday, November 11th.

Co-Diagnostics Stock Up 0.3 %

NASDAQ:CODX opened at $0.74 on Thursday. Co-Diagnostics, Inc. has a 12 month low of $0.67 and a 12 month high of $2.23. The firm’s 50 day moving average is $0.89 and its 200 day moving average is $1.14.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.